期刊文献+

HPLC-UV法检测人血浆中莫西沙星的浓度 被引量:3

下载PDF
导出
摘要 目的建立人血浆中莫西沙星检测的高效液相色谱方法。方法血浆经高氯酸沉淀,以ZORBAX XDB-C18为色谱柱,柱温30℃;流动相为乙腈-水-0.1%TFA,流速为1.0 mL/min;以加替沙星为内标,检测波长为296nm。结果莫西沙星浓度在0.05-8.00 mg/L范围内线性关系良好(r=0.9999);定量下限为0.05 mg/L;高、中、低三个浓度的相对回收率分别为(100.33±4.55)%(、102.87±2.08)%和(99.97±1.59)%;日内RSD分别为4.02%、3.26%和1.43%,日间RSD分别为5.35%、3.31%和1.81%。结论高效液相色谱紫外分光光度法准确可靠、简便快速,适用于人血浆中莫西沙星浓度的测定及其药代动力学研究。
出处 《浙江实用医学》 2010年第5期402-404,共3页 Zhejiang Practical Medicine
  • 相关文献

参考文献8

二级参考文献54

共引文献51

同被引文献32

  • 1张翠莲,Charles H.Nightingale,David P.Nicolau.反相HPLC测定培养基中莫西沙星含量的方法学研究[J].中国药学杂志,2004,39(9):699-701. 被引量:11
  • 2张吟,陈一农,陈文发.固相萃取-高效液相色谱法测定人血清中莫西沙星浓度[J].中国医院药学杂志,2007,27(4):481-483. 被引量:24
  • 3Deshpande D, Srivastava S, Meek C, et al. Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection [ J ]. Antimicrob Agents Chemother ,2010 ,54( 6 ) :2534.
  • 4Tobin CM, Sunderland J, White LO, et al. An isocratic high performance liquid chromatography (HPLC) assay for moxifloxacin, a new 8-methoxyquinolone [ J ]. J Antimicrob Chemother , 1998,42(2) :278.
  • 5Barth J, Jager D, Mundkowski R, et al. Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment [J]. J Antimicrob Chemother ,2008,62 ( 3 ) :575.
  • 6Ferrara AM. A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP) [ J ]. Clin Interv Aging, 2007,2 ( 2 ) : 179.
  • 7Skalioti C, Tsaganos T, Stamatiadis D, et al. Pharmacokinetics of moxifloxacin in patients undergoing continuous ambulatory peritoneal dialysis [ J ]. Perit Dial Int,2009,29(5) :575.
  • 8Respaud R, Grayo S, Singlas E, et al. High-performance li- quid chromatography assay for moxifloxacin in brain tis- sue and plasma: validation in a pharmacokinetic study in a murine model of cerebral listeriosis[J].J Anal Methods Chem,2012(2012) :436 349.
  • 9Peloquin CA, Hadad D J, Molino LP, et al. Population ph- armacokinetics of levofloxacin, gatifloxacin, and moxi- floxacin in adults with pulmonary tuberculosis[J]. Antimi- crob Agents Chemother, 2008,52 (3) : 852.
  • 10Deryke CA, Du X, Nicolau DE Evaluation of bacterial ki- lls when modelling the bronchopulmonary pharmacokinet- ic profile of moxifloxacin and levofloxaein against parC-containing isolates of Streptococcus pneumoniae[J]. JAntimicrob Chemother,2006,58 (3) : 601.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部